Reimmunization following early immunization with measles vaccine: a prospective study

Area of Science:

• Pediatrics
• Immunology
• Vaccinology

Background:

• Measles remains a significant public health concern, necessitating effective immunization strategies.
• Infant immunization schedules aim to provide timely protection against preventable diseases.
• The optimal timing for measles vaccination in infants at high risk of exposure is a critical consideration.

Purpose of the Study:

• To evaluate the immunogenicity and antibody response in infants receiving early measles vaccination.
• To determine if early measles immunization impacts the response to combined measles, mumps, and rubella (MMR) vaccination at 15-18 months of age.
• To assess the safety and efficacy of a two-dose measles vaccination strategy.

Main Methods:

• A prospective study design involving two groups of infants (control and experimental).
• Infants in the experimental group received measles vaccine between 7-12 months; the control group did not.
• Antibody levels were measured at study entry, before MMR vaccination, and after MMR vaccination at 15-18 months.

Main Results:

• At study entry (7-12 months), 14 of 127 infants had pre-existing measles antibodies.
• Prior to MMR vaccination (15-18 months), 80% of the early-vaccinated group and 26% of the control group had detectable antibodies.
• Following MMR vaccination, 94% of the early-vaccinated group and 95% of the control group demonstrated detectable antibody levels.

Conclusions:

• Early measles immunization does not interfere with the immune response to subsequent MMR vaccination.
• These findings support early measles vaccination for infants at high risk of exposure.
• Re-immunization with MMR at 15 months of age is recommended for sustained protection.